miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42.
about
Identification of novel targets for miR-29a using miRNA proteomicsAn in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinomamiRNA response to DNA damageEpigenetic alterations in agingDownregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma developmentmiR-221 is required for endothelial tip cell behaviors during vascular developmentMicroRNAs: new players in cardiac injury and protectionmiRNAs Signature in Head and Neck Squamous Cell Carcinoma Metastasis: A Literature ReviewNew Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid BiopsiesMicroRNA aberrations: An emerging field for gallbladder cancer managementRegulation of Mutant p53 Protein ExpressionDiagnostic and prognostic value of circulating microRNAs in heart failure with preserved and reduced ejection fractionMicroRNAs as pharmacological targets in diabetesThe role of miR-29b in cancer: regulation, function, and signalingNoncoding RNAs in DNA repair and genome integrityInfluence of miRNA in insulin signaling pathway and insulin resistance: micro-molecules with a major role in type-2 diabetesRho GTPase regulation by miRNAs and covalent modificationsRole of microRNAs in the reperfused myocardium towards post-infarct remodellingMicroRNAs in the pathophysiology and treatment of status epilepticusMicroRNA in cervical cancer: OncomiRs and tumor suppressor miRs in diagnosis and treatmentImpact of Nutrition on Non-Coding RNA Epigenetics in Breast and Gynecological CancerMicroRNA dysregulation in the spinal cord following traumatic injuryAn intronic microRNA links Rb/E2F and EGFR signalingSmall-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growthExamination of the expanding pathways for the regulation of p21 expression and activity.The role of microRNAs in regulating myocardial ischemia reperfusion injuryUpregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture modelTemporal microRNA expression during in vitro myogenic progenitor cell proliferation and differentiation: regulation of proliferation by miR-682The somatic genomic landscape of glioblastomaThe oncogenic role of Yin Yang 1The cardiac transcription network modulated by Gata4, Mef2a, Nkx2.5, Srf, histone modifications, and microRNAsMicroRNA-29a inhibited epididymal epithelial cell proliferation by targeting nuclear autoantigenic sperm protein (NASP)Expression and cellular localization of microRNA-29b and RAX, an activator of the RNA-dependent protein kinase (PKR), in the retina of streptozotocin-induced diabetic ratsmiRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumorsMicroRNA expression profiling of the porcine developing brainExpression and localization of microRNAs in perinatal rat pancreas: role of miR-21 in regulation of cholesterol metabolismApoptosisDifferential microRNA expression and virulence of avian, 1918 reassortant, and reconstructed 1918 influenza A viruses.MicroRNAs induced in melanoma treated with combination targeted therapy of Temsirolimus and BevacizumabIdentifying cancer-related microRNAs based on gene expression data.
P2860
Q21090874-AC10CE20-4937-4CCF-92A1-CF1C82DD1860Q21202158-9EB07448-1FF4-4F5C-BBB9-AA252CF2D26CQ24594312-3EA37EFC-D0CC-4514-ACEA-AE23FB36D81BQ24625376-C47E20B8-7736-4B4D-A256-EBA1EC9FB64CQ24628811-34385F33-D9DB-4973-AD94-30A2CE5B2804Q24630712-E1400174-5A87-40A6-AFBC-159B7AD1DD9EQ24635236-330D97BD-D27B-4F03-9C68-3101E39E6B08Q26747138-0A4F73D8-42A2-4B3D-A125-A54D7B4F7BE8Q26748881-7D59DDEC-E4DD-404C-A2B9-2BE400891D1BQ26768416-7BB32FB6-A4C3-44C9-8480-9B828FA27395Q26770579-CCD8A700-3291-4957-97C2-8DE2EDE85F03Q26771125-84F50096-7BF3-4C76-96B2-D91C81D334B2Q26824024-AC55B66A-C014-4AFD-AC46-34592AA1A042Q26851543-A9840244-89BE-43F8-AF8A-B5ABCD8AE3A7Q26864697-47809164-5F83-4416-85FF-AD22DB7E31F7Q26865641-B130B212-F8A2-4029-9E59-5CA528A434A5Q26999290-E86C3967-7848-4E4F-B322-0D18D80B96B2Q27000076-5FD861BA-041B-4AF3-84FE-5C956294F235Q27004814-3DCAE60D-C8EE-4349-B315-9E1A5B20EA27Q27011808-E3B025CA-1529-41DF-BC5C-CE320AD0A296Q27016123-16316D80-AEBA-43CA-AD48-F6CACCC11100Q27305161-4B286BD2-361A-4B58-BB31-1329C651B6ABQ27314824-481F4374-C82C-49C2-8069-063C41E8CB38Q27661276-68DD2CEB-5AE9-4BE7-B80A-413F8C2F69F5Q27692024-7D21B2E1-B67B-4FFE-90D0-0597AD9296C3Q28088604-32E5D0EB-9FA0-40DC-BD50-8C81B9F2D8F9Q28114928-384F5F0C-7598-41A1-8100-0B0C30211C91Q28293277-F01DB313-3561-4CBC-B322-C68DE394107FQ28300185-A47C9FC1-C746-4632-9E47-7DD3586CBD56Q28385924-62CD3F6F-6888-4A8B-93C0-68632F407CF9Q28512635-C0FAB145-AFE7-4948-A596-E03D6BA781E8Q28566117-9388D0BD-6D0F-4A0A-9A46-2D3FDA105EC7Q28577524-1DE701A8-F3D9-480F-AD63-E2A00743424AQ28742532-1902034A-7DBC-4D22-ADFB-6064E0284E5FQ28743662-7F73F6D5-2A30-4232-9C2C-6C3DA3B0AF8FQ28744044-23714F64-6432-42C4-A46C-6614C61540BAQ29892216-67DC965F-8982-4673-A438-52FBA7705F31Q30408164-A6F70004-1974-4A03-A2B1-FB06F0FB6208Q30415894-87DF1C3B-6855-4415-91B2-10F793AA11B2Q30878074-50FBF06D-DEC4-4C65-8AFC-29E50905638B
P2860
miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42.
@en
miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42.
@nl
type
label
miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42.
@en
miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42.
@nl
prefLabel
miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42.
@en
miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42.
@nl
P2093
P2860
P356
P1476
miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42.
@en
P2093
Jin-Wu Nam
Jung Hyun Lee
Seong-Yeon Park
V Narry Kim
P2860
P2888
P356
10.1038/NSMB.1533
P577
2008-12-14T00:00:00Z